Braavos Investment Advisers

PQShield Ltd specializes in post-quantum cryptographic solutions aimed at securing technology infrastructures against potential threats posed by quantum computing. Founded in 2018 and based in Oxford, United Kingdom, the company develops a range of products including PQSoC, a toolkit for post-quantum system on chip crypto co-processors, PQSDK, which integrates post-quantum primitives with the OpenSSL API, and PQE2E, a software development toolkit designed for secure data in transit messaging. PQShield's innovations help businesses transition from traditional cryptographic standards to quantum-secure alternatives, ensuring the protection of sensitive data and communications. The company is actively involved in standardization efforts globally, advancing cybersecurity practices in the face of evolving technological challenges.

OxCCU specializes in renewable energy technology aimed at fostering a circular economy for fuels, chemicals, and plastics. The company’s innovative approach utilizes carbon dioxide extracted from the atmosphere, hydrogen sourced from water, and renewable electricity to produce sustainable fuels, chemicals, and biodegradable plastics. By doing so, OxCCU enables clients to adopt more environmentally friendly products, contributing to a more sustainable future.

Oxford Ionics is a quantum computing startup focused on advancing the development of reliable quantum computers through its innovative use of trapped-ion technology. By combining high-performance qubits with noiseless electronic qubit control, the company offers solutions that allow for precise manipulation of qubits with minimal noise. This technology supports the creation of scalable quantum chips using standard semiconductor fabrication methods, which enhances efficiency and facilitates significant progress in the quantum computing market. Clients benefit from improved computational capabilities, enabling them to tackle complex problem-solving tasks more effectively.

Osler Diagnostics is a UK-based company focused on providing accessible health diagnostics. Established in 2017 from research at the University of Oxford, Osler has developed the Osler Origin, a portable laboratory capable of delivering lab-quality diagnostics anywhere, anytime. This innovative device requires only a drop of blood to test for a wide range of biomarkers, allowing users to monitor various health markers conveniently. Osler aims to serve diverse healthcare settings globally, empowering individuals to understand and manage their health more effectively. The company is headquartered in Oxford, UK.

CHARM Therapeutics is focused on developing innovative medicines using advanced 3D deep learning and drug discovery technologies. The company's platform aims to address undruggable disease targets, providing healthcare professionals with effective treatment options for challenging medical conditions. By leveraging cutting-edge technology, CHARM Therapeutics seeks to create transformative therapies that have the potential to significantly improve patient outcomes.

First Light Fusion Limited, founded in 2011 and based in Begbroke, United Kingdom, specializes in advanced implosion processes for electricity generation through inertial confinement fusion. The company originated as a spin-out from the University of Oxford and actively engages in researching and developing sustainable renewable energy solutions. It employs a team of engineers and physicists and collaborates with several academic institutions, including the University of Oxford, Warwick University, UCL, and Imperial College London. First Light Fusion focuses on harnessing fundamental physics to discover new energy sources, utilizing detailed numerical simulations and experimental validation in its research efforts.

SpyBiotech Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in the development of innovative vaccines using a proprietary technology known as molecular superglue. This platform allows for the rapid creation of bonding vaccines by attaching antigens to viruses and other particles, enhancing the vaccine development process. By leveraging this unique approach, SpyBiotech aims to provide medical institutions and research centers with more effective vaccines that can be developed in a shorter timeframe, ultimately improving immunity against various diseases, including bacterial infections.

Stockbit is an investment community based in Indonesia that facilitates the sharing of stock-related ideas, news, and financial information in real-time. The platform allows users to create profiles, follow specific stocks, and engage with preferred investors to exchange valuable insights. By focusing on the Indonesian market, Stockbit offers tools for monitoring stock price trends and provides comprehensive financial data, enabling individuals and investors to discuss, analyze, and make informed investment decisions. This community-driven approach fosters collaboration among users, enhancing their investment strategies and knowledge.